4 results
Primary Study Objective:To assess the efficacy and safety of the co-administration of low-dose pegvisomant (40 mg, administered via subcutaneous injection given once a week) and long-acting somatostatin analogs (administered once monthly) on the…
The primary study objective is to assess the proportion of patients who remain within the IGF-I age adjusted normal limits with pasireotide LAR (60 mg) monotherapy, after 24 weeks of treatment.Secondary study objectives are assessment of the…
To assess the immunomodulatory effects of erythromycin and clindamycin in healthy volunteers.
The goal of the ARB-PMCF study is to evaluate the safety and performance of Abbott annuloplasty devices used in the surgical repair of mitral and tricuspid regurgitation for five years from implantation.The ARB-PMCF study aims to meet the EU Medical…